Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMXB-A in Autism
NCT02111551Phase 1Terminated
- Sponsor
- University of Colorado Denver
- Start
- Jun 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dmxb-a in Autism Spectrum Disorder (ASD) (3 arms), sponsored by University of Colorado Denver. Primary endpoints: Repeatable Battery for the Assessment of Neuropsychological Status Total Scale Score, Continuous Performance Test and 2 more. Started Jun 2015; status: terminated.
02
Drugs
dmxb-a
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02111551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02111551.